The primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood glucose levels without causing hypoglycaemia when used alone [17] [18] Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs satiety and reduces postprandial glucose excursions Reducing appetite through central nervous system pathways, particularly in the hypothalamus, leading to decreased caloric intake and weight loss It's important to note that while GLP-1 receptor agonists have a low risk of hypoglycaemia when used alone, this risk increases when combined with insulin or sulfonylureas
Also, had breast augmentation, which they made me feel comfortable
They have to take it for eight months
If youre in perimenopause or think perimenopause could be starting and youre starting injections, track your symptoms and reach out to a clinician for support
Kenley, Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans, J